Nasdaq:US$14.65 (-0.06) | HKEX:HK$22.88 (-0.18) | AIM:£2.19 (+0)
News & Presentations
Previous Article   |   Next Article
Presentations, Scientific Publications | 27 Sep 2015

ESMO 2015: Phase II trial of fruquintinib in metastatic colorectal cancer

1 items
View PDF